Analyst Viewpoint
Increase in prevalence of chronic respiratory conditions is fueling the asthma spacers market share. Chronic respiratory diseases, such as asthma and bronchitis, are the most common non-communicable illnesses worldwide. Rise in air pollution, surge in geriatric population, and worsening lifestyle are key factors leading to growth in cases of asthma.
Rise in clinical acceptance of inhaled therapies is augmenting the asthma spacers market revenue. Enhanced awareness about the benefits of inhaled therapies increases the need for asthma spacers as they assist in improving treatment outcomes by efficiently administrating the right dosage of medication to the lungs.
Prominent players operating in the global landscape are investing substantially in the R&D of customized inhaler spacers for children and elderly patients suffering from asthma and other respiratory diseases.
Asthma is a common chronic respiratory illness that affects airways in the lungs. Common symptoms of the disease include wheezing, coughing, shortness of breath, and chest tightness. The difficulty in breathing is caused due to inflammation or narrowing of the airways in the lungs.
Asthma spacers are medical devices that are applied along with inhalers to deliver medicine more effectively to the lungs. A spacer is a tube-like equipment that coordinates the process of pressing the puffer and breathing in. It assists in administering the optimum dosage of medicine by slowing down the process and allowing the patient to take multiple breaths, without forceful deep breathing.
Surge in cases of asthma is boosting the global asthma spacers market landscape. Rise in awareness about respiratory conditions, their symptoms, and treatments is also augmenting the market progress.
Chronic respiratory illnesses are the most common non-communicable diseases globally. This is primarily due to the rise in air pollution, smoking, and sedentary lifestyle. An increase in the geriatric population worldwide is also a key factor in the increase in the prevalence of respiratory issues such as asthma, bronchitis, and pulmonary diseases.
According to a report by SingleCare, more than 339 million people globally suffer from asthma. As per the Asthma and Allergy Foundation of America, one in thirteen people in the U.S. have asthma and nearly 5 million children in the country suffer from the disease.
Surge in cases of chronic respiratory diseases is boosting the demand for therapeutic and management devices such as asthma spacers. Spacers allow for optimum wellness by ensuring efficient delivery of medication to the lungs. Their application reduces medication wastage, fosters better disease management, and improves drug deposition.
Healthcare professionals worldwide are accepting the benefits of inhaled therapies for the treatment and management of respiratory diseases. Inhaled therapies offer targeted delivery of medications directly to the lungs, ensuring rapid and efficient absorption, and thereby improving treatment outcomes.
Asthma spacers reduce the chances of improper breathing techniques, which might mitigate the efficiency of medication or lead to the administration of improper dosage. Growth in awareness about the benefits of inhalation therapeutics in both healthcare workers and patients is propelling the asthma spacers industry.
Spacer technologies in asthma management help reduce the risks of side effects from asthma drugs. Increase in investment in the R&D of advanced spacer technologies that cater to the specific needs of children and older adults is bolstering the asthma spacers market opportunities.
According to a recent asthma spacers market analysis, North America had the largest share in 2022. Presence of a well-established healthcare sector, rise in awareness about chronic respiratory illnesses, and R&D of inhaling solutions are augmenting the market dynamics of the region.
As per the National Center for Health Statistics, in 2022, 4.6% of adults in the U.S. were diagnosed with Chronic Obstructive Pulmonary Disease (COPD), emphysema, or chronic bronchitis. The report also states that the number of deaths due to chronic lower respiratory diseases (including asthma) in the country was 142,342 in 2021.
According to the latest asthma spacers market overview, Asia Pacific is a lucrative market due to the high prevalence of asthma, a surge in the elderly population, and worsening air pollution. According to the Global Asthma Report 2022, an estimated 35 million people in India suffer from asthma. The National Center for Biotechnology Information reports that nearly 45.7 million adults in China suffer from asthma.
According to recent asthma spacers market trends, prominent manufacturers are investing heavily in the development of inhaler chambers and inhaler spacers. They are developing advanced asthma inhaler spacers for elderly patients as the global geriatric population is rising significantly.
Trudell Medical International, PARI GmbH, GSK plc, CONMED Corporation, Medical Developments International, Koninklijke Philips N.V, Merck KGaA, and AstraZeneca are key manufacturers of asthma spacers.
These companies have been profiled in the asthma spacers market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 1.8 Bn |
| Market Forecast Value in 2031 | US$ 2.6 Bn |
| Growth Rate (CAGR) | 4.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Regions Covered |
|
| Countries Covered |
|
| Market Segmentation |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 1.8 Bn in 2022
It is projected to advance at a CAGR of 4.1% from 2023 to 2031
Increase in prevalence of chronic respiratory conditions and rise in clinical acceptance of inhaled therapies
The aerochamber product type segment held the largest share in 2022
North America was the leading region in 2022
Trudell Medical International, PARI GmbH, GSK plc, CONMED Corporation, Medical Developments International, Koninklijke Philips N.V, Merck KGaA, and AstraZeneca
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Asthma Spacers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Asthma Spacers Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Asthma Spacers Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Aerochamber
6.3.2. Optichamber
6.3.3. Volumatic
6.3.4. Inspirease
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Asthma Spacers Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Retail Pharmacy
7.3.2. Hospital Pharmacy
7.3.3. E-commerce
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Asthma Spacers Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Asthma Spacers Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product Type, 2017–2031
9.3.1. Aerochamber
9.3.2. Optichamber
9.3.3. Volumatic
9.3.4. Inspirease
9.3.5. Others
9.4. Market Value Forecast, by Distribution Channel, 2017–2031
9.4.1. Retail Pharmacy
9.4.2. Hospital Pharmacy
9.4.3. E-commerce
9.5. Market Value Forecast, by Country, 2017–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product Type
9.6.2. By Distribution Channel
9.6.3. By Country
10. Europe Asthma Spacers Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Aerochamber
10.3.2. Optichamber
10.3.3. Volumatic
10.3.4. Inspirease
10.3.5. Others
10.4. Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Retail Pharmacy
10.4.2. Hospital Pharmacy
10.4.3. E-commerce
10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Distribution Channel
10.6.3. By Country/Sub-region
11. Asia Pacific Asthma Spacers Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Aerochamber
11.3.2. Optichamber
11.3.3. Volumatic
11.3.4. Inspirease
11.3.5. Others
11.4. Market Value Forecast, by Distribution Channel, 2017–2031
11.4.1. Retail Pharmacy
11.4.2. Hospital Pharmacy
11.4.3. E-commerce
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Distribution Channel
11.6.3. By Country/Sub-region
12. Latin America Asthma Spacers Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Aerochamber
12.3.2. Optichamber
12.3.3. Volumatic
12.3.4. Inspirease
12.3.5. Others
12.4. Market Value Forecast, by Distribution Channel, 2017–2031
12.4.1. Retail Pharmacy
12.4.2. Hospital Pharmacy
12.4.3. E-commerce
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Distribution Channel
12.6.3. By Country/Sub-region
13. Middle East & Africa Asthma Spacers Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Aerochamber
13.3.2. Optichamber
13.3.3. Volumatic
13.3.4. Inspirease
13.3.5. Others
13.4. Market Value Forecast, by Distribution Channel, 2017–2031
13.4.1. Retail Pharmacy
13.4.2. Hospital Pharmacy
13.4.3. E-commerce
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Distribution Channel
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Trudell Medical International
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. PARI GmbH
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. GSK plc
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. CONMED Corporation
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Medical Developments International
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Koninklijke Philips N.V
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Merck KGaA
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. AstraZeneca
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
List of Tables
Table 01: Global Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 03: Global Asthma Spacers Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Asthma Spacers Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 06: North America Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 07: Europe Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: Europe Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 10: Asia Pacific Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 12: Asia Pacific Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 13: Latin America Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Latin America Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 16: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Asthma Spacers Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Asthma Spacers Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Asthma Spacers Market Value Share, by Product Type, 2022
Figure 04: Global Asthma Spacers Market Revenue (US$ Mn), by Distribution Channel, 2022
Figure 05: Global Asthma Spacers Market Value Share, by Distribution Channel, 2022
Figure 06: Global Asthma Spacers Market Value Share, by Region, 2022
Figure 07: Global Asthma Spacers Market Value (US$ Mn) Forecast, 2023–2031
Figure 08: Global Asthma Spacers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 09: Global Asthma Spacers Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 10: Global Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 11: Global Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 12: Global Asthma Spacers Market Value Share Analysis, by Region, 2022 and 2031
Figure 13: Global Asthma Spacers Market Attractiveness Analysis, by Region, 2023-2031
Figure 14: North America Asthma Spacers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 15: North America Asthma Spacers Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Asthma Spacers Market Value Share Analysis, by Country, 2022 and 2031
Figure 17: North America Asthma Spacers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 18: North America Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 19: North America Asthma Spacers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 20: North America Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 21: Europe Asthma Spacers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 22: Europe Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 23: Europe Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 24: Europe Asthma Spacers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 25: Europe Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 26: Europe Asthma Spacers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 27: Europe Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 28: Asia Pacific Asthma Spacers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 29: Asia Pacific Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 30: Asia Pacific Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 31: Asia Pacific Asthma Spacers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 32: Asia Pacific Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 33: Asia Pacific Asthma Spacers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 34: Asia Pacific Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 35: Latin America Asthma Spacers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 36: Latin America Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Latin America Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 38: Latin America Asthma Spacers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 39: Latin America Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 40: Latin America Asthma Spacers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 41: Latin America Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Figure 42: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 43: Middle East & Africa Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 44: Middle East & Africa Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Middle East & Africa Asthma Spacers Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 46: Middle East & Africa Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 47: Middle East & Africa Asthma Spacers Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 48: Middle East & Africa Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Asthma Spacers Market
